Nested PCR employing degradable primers
View Patent ↗The invention is directed to one-tube nested nucleic acid amplification methods, as well as compositions for performing these methods, which employ one or more outer primers containing one or more exo-sample nucleotides and inner primers. Nested amplification reactions are performed in these methods in the presence of an agent that degrades the exo-sample-nucleotide-containing primers in time course fashion during the PCR cycles.
1. A method for amplifying a target nucleic acid sequence present in a template nucleic acid molecule, said method comprising:
(a) assembling an amplification reaction mixture comprising:
(1) the template,
(2) an outer primer pair each of which comprises a sequence with sufficient complementarity to a portion of the template to anneal to the template in an amplification reaction, wherein at least one member of the outer primer pair contains at least one exo-sample nucleotide;
(3) at least one inner primer that comprises a sequence with sufficient complementarity to a portion of the template to anneal to the template in an amplification reaction, wherein the portion of the template to which the inner primer anneals is between the portions of the template to which the outer primers anneal; and
(4) an agent capable of degrading an exo-sample nucleotide; and
(b) conducting an amplification reaction using the amplification reaction mixture;
wherein the agent capable of degrading an exo-sample nucleotide is present in the reaction mixture prior to amplification with the outer primer pair.
2. The method of claim 1 , wherein degrading an exo-sample nucleotide in an outer primer results in degradation of the outer primer.
3. The method of claim 1 , wherein the agent is an enzyme.
4. The method of claim 3 , wherein the enzyme is a glycosylase.
5. The method of claim 4 , wherein the glycosylase is a DNA glycosylase.
6. The method of claim 4 , wherein the glycosylase is selected from the group consisting of uracil-DNA glycosylase, UNGs, UNG1, TAG, alkA, MAG, MAG1, N-methyl-purine glycosylase, EndoIII, EndoVIII, EndoIX, NTG1, NTH, hydroxy-methyl-DNA glycosylase, formyluracil-DNA glycosylase; 2,6-dihydroxy-5N-formamiodopyrimidine DNA glycosylase, OGG1, OGG2, S3, PDG, and 5-methyl-cytosine-DNA glycosylase.
7. The method of claim 1 , wherein the exo-sample nucleotide is a nucleotide selected from the group consisting of deoxyuridine, bromodeoxyuridine, 7-methylguanine, 5,6-dihdro-5,6-dihydroxydeoxythimidin- e, 3-methyldeoxadenosine, inosine, 5-bromo-deoxycitidine, 5-methyldeoxycitidine, 5-bromodeoxyuridine, O-6-methyl-deoxyguanosine, 5-iododeoxyuridine, 8-oxo-deoxyguanine, ethanoadenine, and 5,6-dihydrouracil.
8. The method of claim 1 , wherein at least one of the outer primers is from about 6 nucleotides to about 1000 nucleotides in length.
9. The method of claim 1 , wherein at least one of the inner primers is from about 6 nucleotides to about 1000 nucleotides in length.
10. The method of claim 1 , wherein the target nucleic acid sequence is amplified by polymerase chain reaction.
11. The method of claim 1 , wherein the target nucleic acid sequence is amplified by two or more polymerase chain reactions.
12. The method of claim 11 , wherein the polymerase chain reaction is a reverse-transcriptase polymerase chain reaction or a rapid cycle capillary polymerase chain reaction.